Carlyle Group Inc. Q4 2023 Filing
Filed February 2, 2024
Portfolio Value
$2079.2T
Holdings
25
Report Date
Q4 2023
Filing Type
13F-HR
All Holdings (25 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | QDELQuidelortho Corp | 12,460,183 | $918.3T | 44.17% | |
| 2 | GTMZoomInfo Technologies Inc | 35,244,474 | $651.7T | 31.34% | |
| 3 | SLNOSoleno Therapeutics Inc | 2,857,804 | $115.0T | 5.53% | |
| 4 | VTRUVitru Ltd | 6,246,471 | $98.4T | 4.73% | |
| 5 | GETYGetty Images Holdings Inc | 9,394,319 | $49.3T | 2.37% | |
| 6 | VRNAVerona Pharma Plc | 2,457,500 | $48.8T | 2.35% | |
| 7 | GDSGDS Hldgs Ltd | 4,072,624 | $37.1T | 1.79% | |
| 8 | PHATPhathom Pharmaceuticals Inc | 3,496,808 | $31.9T | 1.54% | |
| 9 | HLVXHillevax Inc | 1,838,486 | $29.5T | 1.42% | |
| 10 | VERAVera Therapeutics Inc | 1,438,155 | $22.1T | 1.06% | |
| 11 | SMHISeacor Marine Hldgs Inc | 1,314,164 | $16.5T | 0.80% | |
| 12 | INVHInvitation Homes Inc | 477,500 | $16.3T | 0.78% | |
| 13 | CUBECubeSmart | 220,500 | $10.2T | 0.49% | |
| 14 | SPRBSpruce Biosciences Inc | 2,896,518 | $8.4T | 0.40% | |
| 15 | JSPRJasper Therapeutics Inc | 8,761,891 | $6.7T | 0.32% | |
| 16 | OKURReneo Pharmaceuticals Inc | 2,698,957 | $4.3T | 0.21% | |
| 17 | SPWRComplete Solaria Inc | 2,745,879 | $4.3T | 0.20% | |
| 18 | TORCEURAdicet Bio Inc | 2,115,385 | $4.0T | 0.19% | |
| 19 | EMSmart Sh Global Ltd | 4,810,209 | $2.4T | 0.12% | |
| 20 | EFTREffector Therapeutics Inc | 4,822,114 | $2.2T | 0.11% | |
| 21 | —Nucana Plc | 3,333,333 | $967.0B | 0.05% | |
| 22 | —Meta Data Limited | 314,400 | $306.0B | 0.01% | |
| 23 | SYRESpyre Therapeutics Inc | 9,620 | $203.9B | 0.01% | |
| 24 | XCUREURExicure Inc | 281,636 | $163.4B | 0.01% | |
| 25 | MTEMEURMolecular Templates Inc | 13,333 | $49.3B | 0.00% |